Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Trial of TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma

NCT03996681 is registered in ClinicalTrials.gov with Suzhou Municipal Hospital as lead sponsor.

NCT NCT03996681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03996681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Trial of TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma
Lead sponsor
Suzhou Municipal Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
July 20, 2019
Completion date
February 1, 2021
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma